Madagascar vs Philippines: Share of pregnant women with HIV that receive antiretroviral therapy
Madagascar
30.0%
in 2024
Philippines
16.0%
in 2024
Madagascar rank
77th
Philippines rank
80th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Madagascar
- Philippines
How they compare
Madagascar currently reports 30.0% against 16.0% in Philippines, a difference of 14.0%.
That makes Madagascar's figure about 1.9 times Philippines's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Philippines ahead.
Madagascar ranks 77th and Philippines ranks 80th of 84 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Philippines in 2.
Head to head by decade
| Decade | Madagascar | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 5.0% | 3.9% | Philippines |
| 2010s | 7.8% | 13.5% | 5.7% | Philippines |
| 2020s | 21.4% | 15.4% | 6.0% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Madagascar or Philippines?
- Madagascar, at 30.0% against 16.0% in Philippines as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Madagascar and Philippines?
- 14.0%, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Madagascar and Philippines rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Madagascar ranks 77th and Philippines ranks 80th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.